Targeted therapies and biological modifiers in urologic tumors: pathobiology and clinical implications
To access this article, please choose from the options below
PII: S0740-2570(08)00060-9
doi:10.1053/j.semdp.2008.07.006
© 2008 Elsevier Inc. All rights reserved.
